Cargando…
Treating Clostridium difficile infections: Should fecal microbiota transplantation be reclassified from investigational drug to human tissue?()
Fecal microbiota transplantation (FMT) has emerged as a highly effective treatment for Clostridium difficile infection (CDI), the most frequent cause of hospital-acquired infectious diarrhea in developed countries and the cause of nearly 30,000 annual deaths in the US. FMT is proving to be more effe...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5935826/ https://www.ncbi.nlm.nih.gov/pubmed/29736438 http://dx.doi.org/10.1016/j.conctc.2015.11.001 |